People · Operator

Dennis Taylor Podlesak

Named in public records as an officer, director or promoter · active 2022–2024 · Pharmaceuticals

1
Companies
2
Filings
$59.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Transposon Therapeutics, Inc.PharmaceuticalsSeries C$59.1M$40.6M2022
Operator network

Dennis Taylor Podlesak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Brent Ahrens · 7 companies · 1 sharedBrent AhrensDennis Podlesak · 6 companies · 1 sharedDennis PodlesakEckard Weber, M.D. · 5 companies · 1 sharedEckard Weber, M.D.Lynne Rollins · 5 companies · 1 sharedLynne RollinsKeith A. Katkin · 3 companies · 1 sharedKeith A. KatkinLynne R. Rollins · 3 companies · 1 sharedLynne R. RollinsJohn Pacifico · 2 companies · 1 sharedJohn PacificoBrent R. Ahrens · 1 companies · 1 sharedBrent R. AhrensBrian Taylor Slingsby, MD, PHD, MPH · 1 companies · 1 sharedBrian Taylor Slin…Daniel R. Hetu, MD, MBA · 1 companies · 1 sharedDaniel R. Hetu, M…Eckard R. Weber, MD · 1 companies · 1 sharedEckard R. Weber, …John R. Pacifico · 1 companies · 1 sharedJohn R. PacificoWilliam R. Harrington, MD, MBA · 1 companies · 1 sharedWilliam R. Harrin…Transposon Therapeutics, Inc. · $59.1M raisedTransposon Therapeuti…Dennis Taylor PodlesakDP
Dennis Taylor Podlesak Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Dennis Taylor Podlesak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brent Ahrens17
Dennis Podlesak16
Eckard Weber, M.D.15
Lynne Rollins15
Keith A. Katkin13
Lynne R. Rollins13
John Pacifico12
Eckard R. Weber, MD11
Brent R. Ahrens11
Brian Taylor Slingsby, MD, PHD, MPH11
William R. Harrington, MD, MBA11
John R. Pacifico11
Daniel R. Hetu, MD, MBA11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.